arrow
M

Miguel Marcos

Institute of Biomedical Research of Salamanca
H指数:41
被引数:5,781

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of GH18 chitinase in Leishmania braziliensis: expression, structural insights, and implications for vaccine and therapeutic development

巴西利什曼原虫中GH18几丁质酶的表征:表达、结构见解及其在疫苗和治疗方法开发中的意义

2026-04-160
OAAI
Immunological biomarkers of non-infectious complications and overall survival in common variable immunodeficiency

非感染性并发症的免疫学生物标志物及其在共同变异免疫缺陷病中的总生存期

2025-10-300
OAAI
bueMicroRNA whole-blood profiling in hospitalized patients with candidemia identified miR-125a-5p and miR-99b-5p as potential biomarkers for Candida albicans bloodstream infection

全血microRNA分析在入住患者中的研究确定了miR-125a-5p和miR-99b-5p可作为念珠菌血流感染的潜在生物标志物

2025-10-220
OAAI
Dysregulated Expression of Canonical and Non-Canonical Glycolytic Enzyme Isoforms in Peripheral Blood from Subjects with Alcohol Use Disorder and from Individuals with Acute Alcohol Consumption

酒精使用障碍患者和急性饮酒个体外周血中经典和非经典糖酵解酶异构体的失调表达

2025-09-220
OAAI
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)

ANCA相关性血管炎的流行病学模式与院内死亡率:来自西班牙国家健康数据(2016–2022年)的见解

2025-06-300
PRE
Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients (vol 16, e0240200, 2021)

基于机器学习开发的住院COVID-19患者疾病严重程度评分及分类模型(卷16,e0240200,2021)

2024-12-050
OA
A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19
2024-08-262
OAAI
Remodeling p38 signaling in muscle controls locomotor activity via IL-15
2024-08-162
OAAI
Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis
2024-05-101
OA
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
2024-02-012
OAAI
In-depth blood immune profiling of Good syndrome patients
2023-11-153
OAAI